OptimizeRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OptimizeRx and other ETFs, options, and stocks.

About OPRX

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. 

CEO
Stephen L. Silvestro
CEOStephen L. Silvestro
Employees
133
Employees133
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1985
Founded1985
Employees
133
Employees133

OPRX Key Statistics

Market cap
98.50M
Market cap98.50M
Price-Earnings ratio
13.92
Price-Earnings ratio13.92
Dividend yield
Dividend yield
Average volume
561.73K
Average volume561.73K
High today
$5.38
High today$5.38
Low today
$5.00
Low today$5.00
Open price
$5.06
Open price$5.06
Volume
443.54K
Volume443.54K
52 Week high
$22.25
52 Week high$22.25
52 Week low
$4.57
52 Week low$4.57

Stock Snapshot

With a market cap of 98.5M, OptimizeRx(OPRX) trades at $5.25. The stock has a price-to-earnings ratio of 13.92.

On 2026-05-14, OptimizeRx(OPRX) stock moved within a range of $5.00 to $5.38. With shares now at $5.25, the stock is trading +5.0% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 443.54K, compared to an average daily volume of 561.73K.

The stock's 52-week range extends from a low of $4.57 to a high of $22.25.

The stock's 52-week range extends from a low of $4.57 to a high of $22.25.

OPRX News

TipRanks 14h
OptimizeRx Earnings Call Balances Growth Hopes and Strains

Optimizerx Corporation ((OPRX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data...

TipRanks 2d
OptimizeRx reports Q1 EPS 14c, consensus 0c

Reports Q1 revenue $18.94M, consensus $18.35M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “We delivered a solid start to 2026, exceeding consensus for...

TipRanks 2d
OptimizeRx Secures New Credit Facility to Boost Flexibility

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own OPRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.